Molecular Engineering of Damaged Myocardium To Enhance Regeneration And Repair
Molecular Engineering of Damaged Myocardium To Enhance Regeneration And Repair
批准号:
8460470
负责人:
MARK ALAN SUSSMAN
金额:
$29.32万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-04-18 至 2013-09-15
关键词:
Adoptive TransferAdultAgingApoptosisApoptoticAppearanceBindingBiologyCardiacCardiac MyocytesCatecholaminesCell CommunicationCell SurvivalCell physiologyCell surfaceCellsCicatrixCollagenDataDependovirusDevelopmentEngineeringEngraftmentEnvironmentExtracellular MatrixExtracellular Matrix ProteinsFOS geneFibronectin ReceptorsFibronectinsFocal Adhesion Kinase 1Functional disorderGoalsHealthcare SystemsHeartHeart DiseasesHeart HypertrophyHeart failureHypertrophyImmediate-Early GenesImmunoblottingImmunohistochemistryIn VitroInfarctionInhibition of ApoptosisInjuryIntegrinsJUN geneLeadMaintenanceMalignant NeoplasmsMediatingMitogen-Activated Protein KinasesModelingModificationMolecularMyocardialMyocardial InfarctionMyocardiumNatural regenerationOxidative StressParticipantPathway interactionsPerformancePhosphorylationPhosphotransferasesPublic HealthReceptor ActivationRegenerative MedicineRegimenRegulationResistanceReverse Transcriptase Polymerase Chain ReactionRoleSignal TransductionSmall Interfering RNAStarvationStem cellsTechniquesTherapeuticTherapeutic InterventionTissuesUnited Statesbasebiological adaptation to stressc-myc Genescardiac repaircell growthcellular engineeringdesignexpectationextracellulargene inductionhuman diseaseimprovedin vivoinnovationmortalitymouse modelnovelnovel strategiesoverexpressionpathological agingprogramsreceptor expressionrepairedresponseresponse to injurysurvivinvector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Discovery of cardiac progenitor cells (CPCs) in the adult heart has led to heightened expectations for novel treatments of cardiac disease. However, adoptive transfer of CPCs results only in transient improvement of cardiac performance because most of the donated cells fail to persist in the hostile milieu of the ischemic scar. Whereas most approaches focus upon enhancing capabilities of stem cells, engineering of the damaged myocardium is a valid alternative strategy to enhance myocardial repair and regeneration. Extracellular matrix (ECM) proteins are pivotal components of the myocardial environment important in maintenance of cellular function. Therefore, the overall goal of this proposal is to improve the survival, proliferation, recruitment, and persistence of CPC in the damaged myocardium by modification of fibronectin (Fn) expression, an ECM protein which correlates highly with spatio-temporal appearance of CPCs in the heart. Our preliminary data delineate a Fn-?5?1-FAK-Pim-1 signaling cascade that regulates CPC growth and survival. The relevance of Fn, ?5?1, FAK and Pim-1 in cardiomyocyte biology are well accepted, however, nothing is known so far about this pathway in CPCs. Therefore, the short term goal is to understand the significance of the Fn-?5? 1-FAK-Pim-1 pathway in CPCs under pathological conditions and extrapolate an innovative therapeutic approach to engineer the extracellular environment of the damaged myocardium to enhance regeneration and repair. Translational potential of these findings will be explored using an adeno-associated virus type 9 (AAV9) vector to express a functional collagen-tethered Fn fragment designed to enhance CPC survival, proliferation, recruitment, and engraftment. Our specific aims are: 1) The Fn-?5?1-FAK-Pim-1 signaling axis is triggered following cardiomyopathic injury in vivo, 2) ?5?1-integrin receptor activation by Fn induces immediate early stress responses, survival, and proliferation via FAK-Pim-1 signaling in CPCs, 3) Robust and persistent CPC- dependent regeneration is mediated by overexpression of a collagen binding Fn fragment delivered by cardiotropic AAV9 vector. The significance of these studies is to define beneficial aspects of the endogenous repair to injury response. The long term goal will be to transfer the Fn fragment expressing AAV9 regimen into human disease establishing an innovative therapeutic concept for regenerative medicine.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Next Generation Regenerative Therapy with Pim-1 Enhanced Cardiac Progenitor Cells
-
批准号:9352458
-
项目类别:
-
资助金额:$26.59万
-
财政年份:2017
-
负责人:MARK ALAN SUSSMAN
-
依托单位:
Enhanced Myocardial Repair with CardioClusters and CardioChimeras
-
批准号:8675146
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2014
-
负责人:MARK ALAN SUSSMAN
-
依托单位:
Enhanced Myocardial Repair with CardioClusters and CardioChimeras
-
批准号:9266810
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2014
-
负责人:MARK ALAN SUSSMAN
-
依托单位:
Enhanced Myocardial Repair with CardioClusters and CardioChimeras
-
批准号:9041013
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2014
-
负责人:MARK ALAN SUSSMAN
-
依托单位:
Beta-adrenergic signaling: double edged sword of myocardial repair
-
批准号:8431986
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2013
-
负责人:MARK ALAN SUSSMAN
-
依托单位:
Beta-adrenergic signaling: double edged sword of myocardial repair
-
批准号:8790766
-
项目类别:
-
资助金额:$36.81万
-
财政年份:2013
-
负责人:MARK ALAN SUSSMAN
-
依托单位:
Cardioprotection by optimizing mTOR activity
-
批准号:8446101
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2013
-
负责人:MARK ALAN SUSSMAN
-
依托单位:
Cardioprotection by optimizing mTOR activity
-
批准号:8792404
-
项目类别:
-
资助金额:$36.81万
-
财政年份:2013
-
负责人:MARK ALAN SUSSMAN
-
依托单位:
Beta-adrenergic signaling: double edged sword of myocardial repair
-
批准号:8996702
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2013
-
负责人:MARK ALAN SUSSMAN
-
依托单位:
Cardioprotection by optimizing mTOR activity
-
批准号:8620713
-
项目类别:
-
资助金额:$36.63万
-
财政年份:2013
-
负责人:MARK ALAN SUSSMAN
-
依托单位:
Beta-adrenergic signaling: double edged sword of myocardial repair
-
批准号:8620715
-
项目类别:
-
资助金额:$36.63万
-
财政年份:2013
-
负责人:MARK ALAN SUSSMAN
-
依托单位:
Molecular Engineering of Damaged Myocardium To Enhance Regeneration And Repair
-
批准号:8276967
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2012
-
负责人:MARK ALAN SUSSMAN
-
依托单位:
Antagonism of myocardial aging and senescence with Pim-1 kinase
-
批准号:8024238
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2011
-
负责人:MARK ALAN SUSSMAN
-
依托单位:
Symposium: AHA Council on Basic Cardiovascular Sciences
-
批准号:8204225
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2011
-
负责人:MARK ALAN SUSSMAN
-
依托单位:
Antagonism of myocardial aging and senescence with Pim-1 kinase
-
批准号:8598928
-
项目类别:
-
资助金额:$36.63万
-
财政年份:2011
-
负责人:MARK ALAN SUSSMAN
-
依托单位:
Antagonism of myocardial aging and senescence with Pim-1 kinase
-
批准号:8208027
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2011
-
负责人:MARK ALAN SUSSMAN
-
依托单位:
Antagonism of myocardial aging and senescence with Pim-1 kinase
-
批准号:8399053
-
项目类别:
-
资助金额:$35.58万
-
财政年份:2011
-
负责人:MARK ALAN SUSSMAN
-
依托单位:
Inducible Notch improves progenitor cell repair of damaged heart
-
批准号:8111875
-
项目类别:
-
资助金额:$22.43万
-
财政年份:2010
-
负责人:MARK ALAN SUSSMAN
-
依托单位:
Control of Cardiac Growth by Ca2+Dependent Phosphorylation of Histones
-
批准号:8072686
-
项目类别:
-
资助金额:$22.43万
-
财政年份:2010
-
负责人:MARK ALAN SUSSMAN
-
依托单位:
Nucleolar disruption in response to cardiomyopathic stress and injury
-
批准号:7878487
-
项目类别:
-
资助金额:$22.43万
-
财政年份:2010
-
负责人:MARK ALAN SUSSMAN
-
依托单位:
海外基金